MAGIC-01: A study of a new vaccine against Marburg virus in adults aged 18 – 55 years

You are invited to take part in a study to investigate a new vaccine against Marburg virus. The study is being led by the Oxford Vaccine Group, which is part of the University of Oxford. The study will take place at the Oxford Vaccine Group, Centre for Clinical Vaccinology & Tropical Medicine (CCVTM).

NIV001

Study Title: NIV001

NIV001: A phase I safety and immunogenicity trial of a Nipah virus vaccine, ChAdOx1 NipahB, in healthy volunteers aged 18-55 years in the UK

BIO-001

 

We are looking for healthy volunteers to take part in a study to find a vaccine against Malaria.